DK175308B1 - En vaccinekomposition omfattende et inaktiveret virus eller bakterium, fremgangsmåde til fremstilling deraf samt anvendelsen af en substans eller en komposition i fremstillingen deraf - Google Patents

En vaccinekomposition omfattende et inaktiveret virus eller bakterium, fremgangsmåde til fremstilling deraf samt anvendelsen af en substans eller en komposition i fremstillingen deraf Download PDF

Info

Publication number
DK175308B1
DK175308B1 DK198805342A DK534288A DK175308B1 DK 175308 B1 DK175308 B1 DK 175308B1 DK 198805342 A DK198805342 A DK 198805342A DK 534288 A DK534288 A DK 534288A DK 175308 B1 DK175308 B1 DK 175308B1
Authority
DK
Denmark
Prior art keywords
virus
inactivated
bacterium
vaccine
composition
Prior art date
Application number
DK198805342A
Other languages
Danish (da)
English (en)
Other versions
DK534288A (da
DK534288D0 (da
Inventor
Dale Bordt
Hans Draayer
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK534288D0 publication Critical patent/DK534288D0/da
Publication of DK534288A publication Critical patent/DK534288A/da
Application granted granted Critical
Publication of DK175308B1 publication Critical patent/DK175308B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C12N2770/20063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DK198805342A 1987-09-28 1988-09-26 En vaccinekomposition omfattende et inaktiveret virus eller bakterium, fremgangsmåde til fremstilling deraf samt anvendelsen af en substans eller en komposition i fremstillingen deraf DK175308B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10182287A 1987-09-28 1987-09-28
US10182287 1987-09-28

Publications (3)

Publication Number Publication Date
DK534288D0 DK534288D0 (da) 1988-09-26
DK534288A DK534288A (da) 1989-03-29
DK175308B1 true DK175308B1 (da) 2004-08-16

Family

ID=22286587

Family Applications (2)

Application Number Title Priority Date Filing Date
DK198805342A DK175308B1 (da) 1987-09-28 1988-09-26 En vaccinekomposition omfattende et inaktiveret virus eller bakterium, fremgangsmåde til fremstilling deraf samt anvendelsen af en substans eller en komposition i fremstillingen deraf
DK198805341A DK175379B1 (da) 1987-09-28 1988-09-26 Anvendelse af transmitterbart svine-gastro-enteritisvirus samt fremgangsmåde til fremstilling af en vaccine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK198805341A DK175379B1 (da) 1987-09-28 1988-09-26 Anvendelse af transmitterbart svine-gastro-enteritisvirus samt fremgangsmåde til fremstilling af en vaccine

Country Status (14)

Country Link
EP (2) EP0310317B1 (de)
JP (2) JP2733844B2 (de)
KR (2) KR890004725A (de)
AT (2) ATE117899T1 (de)
AU (2) AU624339B2 (de)
CA (2) CA1332919C (de)
DE (2) DE3886332T2 (de)
DK (2) DK175308B1 (de)
ES (2) ES2067474T3 (de)
GR (1) GR3015608T3 (de)
IE (2) IE60950B1 (de)
NZ (2) NZ226332A (de)
PT (2) PT88590B (de)
ZA (2) ZA887196B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE117899T1 (de) * 1987-09-28 1995-02-15 Beecham Inc Tgev-virus vom schwein als impfstoff für hunde.
CA2064558C (en) * 1989-09-25 2001-01-30 Ian B. Pragnell Method for inhibiting growth of stem cells
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
EP0460480B1 (de) * 1990-06-07 1996-01-24 Bayer Corporation Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
JPH0813753B2 (ja) * 1992-05-22 1996-02-14 株式会社微生物化学研究所 牛伝染性鼻気管炎ウイルス感染症、牛ウイルス性下痢−粘膜病ウイルス感染症、パラインフルエンザ３型ウイルス感染症、牛ｒｓウイルス感染症および牛アデノ７型ウイルス感染症５種混合生ワクチン
BR9307190A (pt) * 1992-10-05 1999-03-30 Sanofi Animal Health Inc Processo de vacinação de um animal contra um agente infeccioso vacina e kit de vacina
JP2521226B2 (ja) * 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
EP0612532A3 (de) * 1993-02-26 1998-02-04 Solvay Animal Health, Inc. Hunde Coronavirus Impfstoff aus einem Katzen-enterischen Coronavirus
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
US5362442A (en) 1993-07-22 1994-11-08 2920913 Canada Inc. Method for sterilizing products with gamma radiation
RU2142817C1 (ru) * 1993-08-06 1999-12-20 Коннот Лабораториз Лимитед Инактивированные вакцины респираторно-синцитиального вируса
CA2184132C (en) * 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
US6682746B2 (en) 1995-09-21 2004-01-27 Kristina J. Hennessy Adjuvanted vaccine which is substantially free of non-host albumin
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
EP0978286A1 (de) * 1998-08-07 2000-02-09 Bayer Corporation Sich gegenseitig schützende Herpesviruszusammensetzungen vom Pferd und Verfahren zur deren Herstellung und Verwendung
US6682695B2 (en) 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
US6696060B2 (en) 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
US6946098B2 (en) 2001-08-10 2005-09-20 Clearant, Inc. Methods for sterilizing biological materials
US6749851B2 (en) 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
US7252799B2 (en) 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
US20030095890A1 (en) 2001-09-24 2003-05-22 Shirley Miekka Methods for sterilizing biological materials containing non-aqueous solvents
US6783968B2 (en) 2001-09-24 2004-08-31 Clearant, Inc. Methods for sterilizing preparations of glycosidases
US6908591B2 (en) 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CN103709248B (zh) * 2013-12-24 2019-07-16 北京大北农科技集团股份有限公司动物医学研究中心 一种抗猪传染性胃肠炎病毒高免血清及其制备方法
DE202020001666U1 (de) 2020-04-21 2020-06-08 Walther Enßlin Imprägnierung der Oberfläche von Kleidung, Schutzkleidung, Gewebehandschuhen gegen Viren aus den Tröpfchen der Atemluft
DE202020003865U1 (de) 2020-09-11 2021-09-22 Karin Emde Einfangen und Vernichten von Viren und andere Mikroorganismen in Raumluft und Raumluftfiltern
DE102021001635A1 (de) 2021-03-27 2022-09-29 Karin Emde Abfangen und Vernichten von Viren und andere Mikroorganismen auf Oberflächen, in Raumluft, in der Abluft von Staubsaugern und in Raumluftfiltern.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145144A (en) * 1951-08-09 1964-08-18 Takeda Pharmacentical Ind Ltd Process for manufacturing chromium treated vaccines
FR1488212A (fr) * 1964-06-22 1967-07-13 Behringwerke Ag Procédé permettant d'atténuer le virus de la fièvre aphteuse
CH466894A (de) * 1964-09-22 1968-12-31 Diamond Lab Inc Verfahren zur Herstellung eines Vakzins gegen infektiöse Gastroenteritis
US3925544A (en) * 1971-07-12 1975-12-09 Univ Southern Illinois Bovine vaccines and methods of making and using same
US3907986A (en) * 1972-12-18 1975-09-23 Rit Rech Ind Therapeut Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
JPS5531762B2 (de) * 1973-03-28 1980-08-20
DE2860895D1 (en) * 1977-07-22 1981-11-05 Merck & Co Inc Parainfluenza virus vaccine and its preparation
JPS55104215A (en) * 1979-02-06 1980-08-09 Merck & Co Inc Parainfluenza virus vaccine and its manufacture
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines
ATE117899T1 (de) * 1987-09-28 1995-02-15 Beecham Inc Tgev-virus vom schwein als impfstoff für hunde.

Also Published As

Publication number Publication date
ZA887196B (en) 1989-07-26
PT88591A (pt) 1988-10-01
AU2284388A (en) 1989-04-06
IE882909L (en) 1989-03-28
JPH01230532A (ja) 1989-09-14
NZ226333A (en) 1991-09-25
ES2061673T3 (es) 1994-12-16
KR0135426B1 (ko) 1998-04-23
DK534288A (da) 1989-03-29
CA1331562C (en) 1994-08-23
EP0310316A2 (de) 1989-04-05
DK534188A (da) 1989-03-29
DK175379B1 (da) 2004-09-20
KR890004728A (ko) 1989-05-09
GR3015608T3 (en) 1995-06-30
DK534188D0 (da) 1988-09-26
PT88590A (pt) 1988-10-01
IE60950B1 (en) 1994-09-07
DE3886332D1 (de) 1994-01-27
EP0310317B1 (de) 1993-12-15
CA1332919C (en) 1994-11-08
DE3852918D1 (de) 1995-03-16
AU624339B2 (en) 1992-06-11
EP0310317A2 (de) 1989-04-05
EP0310316B1 (de) 1995-02-01
IE66015B1 (en) 1995-11-29
IE882908L (en) 1989-03-28
NZ226332A (en) 1991-10-25
DE3886332T2 (de) 1994-03-31
AU624081B2 (en) 1992-06-04
ZA887195B (en) 1989-07-26
AU2281488A (en) 1989-04-06
EP0310317A3 (en) 1990-02-14
PT88590B (pt) 1993-04-30
EP0310316A3 (en) 1990-02-14
PT88591B (pt) 1992-11-30
DK534288D0 (da) 1988-09-26
JPH01230523A (ja) 1989-09-14
KR890004725A (ko) 1989-05-09
JP2733844B2 (ja) 1998-03-30
DE3852918T2 (de) 1995-07-13
ATE117899T1 (de) 1995-02-15
JP2715114B2 (ja) 1998-02-18
ES2067474T3 (es) 1995-04-01
ATE98680T1 (de) 1994-01-15

Similar Documents

Publication Publication Date Title
DK175308B1 (da) En vaccinekomposition omfattende et inaktiveret virus eller bakterium, fremgangsmåde til fremstilling deraf samt anvendelsen af en substans eller en komposition i fremstillingen deraf
US4693981A (en) Preparation of inactivated viral vaccines
EP0759780A1 (de) Modifizierter,verbesserter,lebender brsv impfstoff
KR20050007402A (ko) 미코플라스마 하이오뉴모니애 및 돼지 바이러스에 대한개선된 배합 백신
HU227431B1 (en) Mycoplasma hyopneumoniae bacterin vaccine
DK162421B (da) Hundeparvovirus-vaccine, fremgangsmaade til fremstilling heraf og virusstamme til brug i vaccinen
US4545987A (en) Psoralen inactivated double-stranded RNA viral vaccines
Larghi et al. Rabies virus inactivation by binary ethylenimine: new method for inactivated vaccine production
US4556556A (en) Vaccine for the prevention of vesicular stomatitis virus infection
Kadiroğlu et al. Optimum processing conditions for a trivalent-inactivated bovine viral diarrhea virus (BVDV) vaccine using field strains and immunogenicity of candidate formulations with different adjuvants
US5200179A (en) Vaccine
El-Bagoury et al. Evaluation of an inactivated combined oil vaccine prepared for foot and mouth disease and bovine ephemeral fever viruses
Benjavongkulchai et al. An immunogenicity and efficacy study of purified chick embryo cell culture rabies vaccine manufactured in Japan
US3366543A (en) Process of attenuating infectious bovine rhinotracheitis viruses
US5911999A (en) Vaccine based on TGEV for protection of dogs against canine coronavirus
EP0386946A1 (de) Katzeninfektiöser Peritonitis-Impfstoff
Chen et al. Adjuvant enhancement of humoral immune response to chemically inactivated bovine viral diarrhea virus
RU2242993C2 (ru) Способ приготовления вакцины для профилактики хламидийных инфекций у человека
Dedek et al. Experience with preparation of an inactivated vaccine against Aujeszky's disease
RU2196608C2 (ru) Бивалентная инактивированная вакцина против болезни тешена
Yehia et al. Efficacy of a lyophilized combined Rift Valley Fever and Pest des Petits Ruminants vaccine
JP3270473B2 (ja) パスツレラ・マルトサイダ・トキソイドワクチン
Abegunde et al. Quality evaluation of two FMD Vaccines Prepared from local Isolates of sero types SAT1 and SAT2 Antigens and Montanide ISA 206 Formulations
US5667785A (en) Vaccine for protection of cats against feline infectious peritonitis
GB2052983A (en) Vaccine for infectious bovine rhinotracheitis

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK